Determinants of agreement between proposed therapeutic windows of platelet function tests in vulnerable patients-Reference-Cited by-同舟云学术

Determinants of agreement between proposed therapeutic windows of platelet function tests in vulnerable patients

Published:2016-09-07 Issue:1 Volume:3 Page:11-17
ISSN:2055-6837
Container-title:European Heart Journal - Cardiovascular Pharmacotherapy
language:en
Short-container-title:Eur Heart J Cardiovasc Pharmacother

Author:

Vries Minka J.A.,Bouman Heleen J.,Olie Renske H.,Veenstra Leo F.,Zwaveling Suzanne,Verhezen Paul W.M.,ten Cate-Hoek Arina J.,ten Cate Hugo,Henskens Yvonne M.C.,van der Meijden Paola E.J.

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/ehjcvp/article-pdf/3/1/11/14112485/pvw026.pdf

Reference33 articles.

1. Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data

2. Clinical Outcome After Primary Percutaneous Coronary Intervention With Drug-Eluting and Bare Metal Stents in Patients With ST-Segment Elevation Myocardial Infarction

3. Consensus and Update on the Definition of On-Treatment Platelet Reactivity to Adenosine Diphosphate Associated With Ischemia and Bleeding

4. Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention

5. Assessment of bleeding risk in patients with coronary artery disease on dual antiplatelet therapy

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validating the Prognostic Utility of the ABCD-GENE Score in Asian Patients with Acute Coronary Syndrome Patients on Clopidogrel;European Cardiology Review;2023-10-31

2. Influence of body weight and body mass index on the chronic pharmacokinetic and pharmacodynamic responses to clinically available doses of ticagrelor in patients with chronic coronary syndromes;Vascular Pharmacology;2023-04

3. Hemostatic biomarkers and antithrombotic strategy in percutaneous left atrial interventions: State-of-the-art review;Thrombosis Research;2022-07

4. Differences in Optimal Platelet Reactivity after Potent P2Y12 Inhibitor Treatment in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention;Journal of Clinical Medicine;2022-04-28

5. Eurasian clinical guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndrome (NSTE-ACS);Eurasian heart journal;2021-11-25